Vitamin E transport, membrane incorporation and cell metabolism: Is α-Tocopherol in lipid rafts an oar in the lifeboat?

Molecular Nutrition and Food Research

Volumn 54, Issue 5, 2010, Pages 631-640

  Lemaire Ewing, Stéphanie ^a,b   Desrumaux, Catherine ^a,b   Néel, Dominique ^a,b   Lagrost, Laurent ^a,b  

^a Chu   (France)

^b UNIVERSITÉ DE BOURGOGNE   (France)

Author keywords

tocopherol; Antioxidant; Cell death; Lipid raft; Signal transduction

Indexed keywords

ABC TRANSPORTER; ALPHA TOCOPHEROL; ANTIOXIDANT; LOW DENSITY LIPOPROTEIN RECEPTOR; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN; PEPTIDE FRAGMENT; PROTEIN PRECURSOR; TAP1 PROTEIN, HUMAN; TAP2 PROTEIN, HUMAN; THYROTROPIN RELEASING HORMONE ASSOCIATED PEPTIDE 3, HUMAN; THYROTROPIN-RELEASING HORMONE-ASSOCIATED PEPTIDE 3, HUMAN;

CELL MEMBRANE; HUMAN; INTESTINE ABSORPTION; LIVER; METABOLISM; REVIEW; SECRETION; TRANSPORT AT THE CELLULAR LEVEL;

ALPHA-TOCOPHEROL; ANTIOXIDANTS; ATP-BINDING CASSETTE TRANSPORTERS; BIOLOGICAL TRANSPORT; CELL MEMBRANE; HUMANS; INTESTINAL ABSORPTION; LDL-RECEPTOR RELATED PROTEINS; LIVER; MEMBRANE MICRODOMAINS; PEPTIDE FRAGMENTS; PROTEIN PRECURSORS; RECEPTORS, LDL; VITAMIN E;

EID: 77952373085     PISSN: 16134125     EISSN: 16134133     Source Type: Journal    
DOI: 10.1002/mnfr.200900445     Document Type: Review

References (87)

1. Pennock, J.-F., Hemming, F.-M., Kerr, J.-D., A reassessment of tocopherol in chemistry. Biochem. Biophys. Res. Commun. 1964, 17, 542-548.
2. Traber, M.-G., Atkinson, J., Vitamin E, antioxidant and nothing more? Free Radic. Biol. Med. 2007, 43, 4-15.
3. Morley, S., Cecchini, M., Zhang, W., Virgulti, A. et al., Mechanisms of ligand transfer by the hepatic tocopherol transfer protein. J. Biol. Chem. 2008, 283, 17797-17804.
4. Brigelius-Flohé, R., Vitamin E: the shrew waiting to be tamed. Free Radic. Biol. Med. 2009, 46, 543-554.
5. Azzi, A., Molecular mechanism of alphα-tocopherol action. Free Radic. Biol. Med. 2007, 43, 16-21.
6. Munteanu, A., Zingg, J.-M., Cellular, molecular and clinical aspects of vitamin E on atherosclerosis prevention. Mol. Aspects Med. 2007, 28, 538-590.
7. Munteanu, A., Zingg, J.-M., Ogru, E., Libinaki, R. et al., Modulation of cell proliferation and gene expression by a-tocopheryl phosphates: relevance to atherosclerosis and inflammation. Biochem. Biophys. Res. Commun. 2004, 318, 311-316.
8. Negis, Y., Meydani, M., Zingg, J.-M., Azzi, A., Molecular mechanism of a-tocopheryl-phosphate transport across the cell membrane. Biochem. Biophys. Res. Commun. 2007, 359,348-353.
9. Reboul, E., Klein, A., Bietrix, F., Gleize, B. et al., Scavenger receptor class B type I (SR-BI) is involved in vitamin E transport across the enterocyte. J. Biol. Chem. 2006, 281, 4739-4745.
10. Anwar, K., Kayden, H.-J., Hussain, M.-M., Transport of vitamin E by differentiated Caco-2 cells. J. Lipid Res. 2006, 47,1261-1273.
11. Anwar, K., Iqbal, J., Hussain, M.-M., Mechanisms involved in vitamin E transport by primary enterocytes and in vivo absorption. J. Lipid Res. 2007, 48, 2028-2038.
12. Reboul, E., Trompier, D., Moussa, M., Klein, A., Landrier, J.-F. et al., ATP-binding cassette transporter A1 is significantly involved in the intestinal absorption of alpha-and gammα-tocopherol but not in that of retinyl palmitate in mice. Am. J. Clin. Nutr. 2009, 89, 177-184.
13. Mardones, P., Rigotti, A., Cellular mechanisms of vitamin E uptake: relevance in alphα-tocopherol metabolism and potential implications for disease. J. Nutr. Biochem. 2004, 15,252-260.
14. Berriot-Varoqueaux, N., Aggerbeck, L.-P., Samson-Bouma, M., Wetterau, J.-R., The role of the microsomal triglyceride transfer protein in abetalipoproteinemia. Annu. Rev. Nutr. 2000,20,663-697.
15. Cooper, A.-D., Hepatic uptake of chylomicron remnants. J. Lipid Res. 1997, 38, 2173-2192.
16. Manor, D., Morley, S., The alphα-tocopherol transfer protein. Vitam. Horm. 2007, 76, 45-65.
17. Gotoda, T., Arita, M., Arai, H., Inoue, K. et al., Adult-onset spinocerebellar dysfunction caused by a mutation in the gene for the alphα-tocopherol-transfer protein. N. Engl. J. Med. 1995, 333, 1313-1318.
18. Shichiri, M., Takanezawa, Y., Rotzoll, D.-E., Yoshida, Y. et al., ATP-Binding cassette transporter A1 is involved in hepatic alphα-tocopherol secretion. J. Nutr. Biochem. 2009, doi:10.1016/j.jnotbio.2009.02.002
19. Kostner, G.-M., Oettl, K., Jauhiainen, M., Ehnholm, C. et al., Human plasma phospholipid transfer protein accelerates exchange/transfer of alphα-tocopherol between lipoproteins and cells. Biochem. J. 1995, 305, 659-667.
20. Desrumaux, C., Deckert, V., Athias, A., Masson, D. et al., Plasma phospholipid transfer protein prevents vascular endothelium dysfunction by delivering alphα-tocopherol to endothelial cells. FASEB J. 1999, 13, 883-892.
21. Jiang, X.-C., Tall, A.-R., Qin, S., Lin, M. et al., Phospholipid transfer protein deficiency protects circulating lipoproteins from oxidation due to the enhanced accumulation of vitamin E. J. Biol. Chem. 2002, 277, 31850-31856.
22. Jiang, X.-C., Qin, S., Qiao, C., Kawano, K. et al., Apolipoprotein B secretion and atherosclerosis are decreased in mice with phospholipid-transfer protein deficiency. Nat. Med. 2001, 7, 847-852.
23. Jiang, X.-C., Li, Z., Liu, R., Yang, X.-P. et al., Phospholipid transfer protein deficiency impairs apolipoprotein-B secretion from hepatocytes by stimulating a proteolytic pathway through a relative deficiency of vitamin E and an increase in intracellular oxidants. J. Biol. Chem. 2005, 280, 18336-18340.
24. Yang, X.-P., Yan, D., Qiao, C., Liu, R.-J. et al., Increased atheroclerotic lesions in apoE mice with plasma phospholipid transfer protein overexpression. Arterioscler. Thromb. Vasc. Biol. 2003, 23, 1601-1607.
25. Schneider, M., Vergés, B., Klein, A., Miller, E.-R. et al., Alterations in plasma vitamin E distribution in type 2 diabetic patients with elevated plasma phospholipid transfer protein activity. Diabetes 2004, 10, 2633-2639.
26. Tzotzas, T., Desrumaux, C., Lagrost, L., Plasma phospholipid transfer protein (PLTP): review of an emerging cardiometabolic risk factor. Obes. Rev. 2009, 10, 403-411.
27. Hacquebard, M., Vandenbranden, M., Malaisse, W.-J., Ruysschaert, J.-M. et al., Vitamin E transfer from lipid emulsions to plasma lipoproteins: mediation by multiple mechanisms. Lipids 2008, 43, 663-671.
28. Masterjohn, C., Effect of cholesteryl ester transfer protein inhibitor on vitamin E transport should be studied. Am. Heart J. 2009, 158, e11.
29. Nakamura, T., Reicher, H., Sattler, W., Comparison of RRRalpha-and all-rac-alphα-tocopherol uptake by permanent rat skeletal muscle myoblasts (L6 cells): effects of exogenous lipoprotein lipase. Lipids 1998, 33, 1001-1008.
30. Martinez, S., Barbas, C., Herrera, E., Uptake of alphα-tocopherol by the mammary gland but not by white adipose tissue is dependent on lipoprotein lipase activity around parturition and during lactation in the rat. Metabolism 2002, 51,1444-1451.
31. Sattler, W., Levak-Frank, S., Radner, H., Kostner, G.-M., Zechner, R., Muscle-specific overexpression of lipoprotein lipase in transgenic mice results in increased alpha-toco-pherol levels in skeletal muscle. Biochem. J. 1996, 318, 15-19.
32. Goti, D., Balazs, Z., Panzenboeck, U., Hrzenjak, A. et al., Effects of lipoprotein lipase on uptake and transcytosis of low density lipoprotein (LDL) and LDL-associated alphα-tocopherol in a porcine in vitro blood-brain barrier model. J. Biol. Chem. 2002, 277, 28537-28544.
33. Traber, M.-G., Kayden, H.-J., Vitamin E is delivered to cells via the high affinity receptor for low-density lipoprotein. Am. J. Clin. Nutr. 1984, 40, 747-751.
34. Cohn, W., Kuhn, H., The role of the low density lipoprotein receptor for alphα-tocopherol delivery to tissues. Ann. N. Y. Acad. Sci. 1989, 570, 61-71.
35. Cohn, W., Goss-Sampson, M.-A., Grun, H., Muller, D.-P., Plasma clearance and net uptake of alphα-tocopherol and low-density lipoprotein by tissues in WHHL and control rabbits. Biochem. J. 1992, 287, 247-254.
36. Mardones, P., Strobel, P., Miranda, S., Leighton, F. et al., Alphα-tocopherol metabolism is abnormal in scavenger receptor class B type I (SR-BI)-deficient mice. J. Nutr. 2002, 132,443-449.
37. Goti, D., Reicher, H., Malle, E., Kostner, G.-M. et al., High-density lipoprotein (HDL3)-associated alphα-tocopherol is taken up by HepG2 cells via the selective uptake pathway and resecreted with endogenously synthesized apolipo-protein B-rich lipoprotein particles. Biochem. J. 1998, 332, 57-65.
38. Kolleck, I., Schlame, M., Fechner, H., Looman, A.-C. et al., HDL is the major source of vitamin E for type II pneumocytes. Free Radic. Biol. Med. 1999, 27, 882-890.
39. Goti, D., Hammer, A., Galla, H.-J., Malle, E., Sattler, W., Uptake of lipoprotein-associated alphα-tocopherol by primary porcine brain capillary endothelial cells. J. Neuro-chem. 2000, 74, 1374-1383.
40. Goti, D., Hrzenjak, A., Levak-Frank, S., Frank, S. et al., Scavenger receptor class B, type I is expressed in porcine brain capillary endothelial cells and contributes to selective uptake of HDL-associated vitamin E. J. Neurochem. 2001, 76,498-508.
41. Hrzenjak, A., Reicher, H., Wintersperger, A., Steinecker-Frohnwieser, B. et al., Inhibition of lung carcinoma cell growth by high density lipoprotein-associated alpha-toco-pheryl-succinate. Cell Mol. Life Sci. 2004, 61, 1520-1531.
42. Trigatti, B., Rayburn, H., Vinals, M., Braun, A. et al., Influence of the high density lipoprotein receptor SR-BI on reproductive and cardiovascular pathophysiology. Proc. Natl. Acad. Sci. USA 1999, 96, 9322-9327.
43. Tachikawa, M., Okayasu, S., Hosoya, K., Functional involvement of scavenger receptor class B, type I, in the uptake of alphα-tocopherol using cultured rat retinal capillary endothelial cells. Mol. Vis. 2007, 13, 2041-2047.
44. Zimmer, S., Stocker, A., Sarbolouki, M.-N., Spycher, S.-E. et al., A novel human tocopherol-associated protein. J. Biol. Chem. 2000, 275, 25672-25680.
45. Kempna, P., Zingg, J.-M., Ricciarelli, R., Hierl, M. et al., Cloning of novel human SEC14p-like proteins: ligand binding and functional properties. Free Radic. Biol. Med. 2003,34,1458-1472.
46. Zingg, J.-M., Kempna, P., Paris, M., Reiter, E. et al., Characterization of three human sec14-like proteins: alphα-tocopherol transport activity and expression pattern in tissues. Biochimie 2008, 90, 1703-1715.
47. van Haperen, R., van Tol, A., van Gent, T., Scheek, L. et al., Increased risk of atherosclerosis by elevated plasma levels of phospholipid transfer protein. J. Biol. Chem. 2002, 277, 48938-48943.
48. Lie, J., de Crom, R., van Gent, T., van Haperen, R. et al., Elevation of plasma phospholipid transfer protein increases the risk of atherosclerosis despite lower apolipoprotein B-containing lipoproteins. J. Lipid Res. 2004, 45, 805-811.
49. Schlitt, A., Bickel, C., Thumma, P., Blankenberg, S. et al., High plasma phospholipid transfer protein levels as a risk factor for coronary artery disease. Arterioscler. Thromb. Vasc. Biol. 2003, 23, 1857-1862.
50. Vikstedt, E., Ye, D., Metso, J., Hildebrand, R. B. et al., Macro-phage phospholipid transfer protein contributes significantly to total plasma phospholipid transfer activity and its deficiency leads to diminished atherosclerotic lesion development. Arterioscler. Thromb. Vasc. Biol. 2007, 27, 578-586.
51. Valenta, D.-T., Ogier, N., Bradshaw, G., Black, A.-S. et al., Atheroprotective potentiel of macrophage-derived phospholipid transfer protein in low-density lipoprotein receptor-deficient mice is overcome by apolipoprotein AI overexpression. Arterioscler. Thromb. Vasc. Biol. 2006, 26, 1572-1578.
52. Ogier, N., Klein, A., Deckert, V., Athias, A. et al., Cholesterol accumulation is increased in macrophages of phospholipid transfer protein-deficient mice: normalization by dietary alphα-tocopherol supplementation. Arterioscler. Thromb. Vasc. Biol. 2007, 27, 2047-2412.
53. Day, J.-R., Albers, J.-J., Lofton-Day, C.-E., Gilbert, T.-L. et al., Complete cDNA encoding human plasma phospholipid transfer protein from human endothelial cells. J. Biol. Chem. 1994, 269, 9388-9391.
54. Desrumaux, C., Risold, P.-Y., Schroeder, H., Deckert, V. et al., Phospholipid transfer protein (PLTP) deficiency reduces brain vitamin E content and increases anxiety in mice. FASEB J. 2005, 19, 296-297.
55. Drouineaud, V., Lagrost, L., Klein, A., Desrumaux, C. et al., Phospholipid transfer protein deficiency reduces sperm motility and impairs fertility of mouse males. FASEB J. 2006,20,794-796.
56. Klein, A., Deckert, V., Schneider, M., Dutrillaux, F. et al., Alphα-tocopherol modulates phosphatidylserine externalization in erythrocytes: relevance in phospholipid transfer protein deficient mice. Arterioscler. Thromb. Vasc. Biol. 2006,26,2160-2167.
57. Mustacich, D.-J., Shields, J., Horton, R.-A., Brown, M.-K., Reed, D.-J., Biliary secretion of alphα-tocopherol and the role of the mdr2 P-glycoprotein in rats and mice. Arch. Biochem. Biophys. 1998, 350, 183-192.
58. Kaempf-Rotzoll, D.-E., Traber, M.-G., Arai, H., Vitamin E and transfer proteins. Curr. Opin. Lipidol. 2003, 14, 249-254.
59. Kluth, D., Landes, N., Pfluger, P., Muller-Schmehl, K. et al., Modulation of Cyp3a11 mRNA expression by alphα-tocopherol but not gamma-tocotrienol in mice. Free Radic. Biol. Med. 2005, 38, 507-514.
60. Bauerfeind, J.-C., The tocopherol content of food and influencing factors. Crit. Rev. Food Sci. Nutr. 1977, 8, 337-382.
61. Abdala-Valencia, H., Cook-Mills, J.-M., VCAM-1 signals activate endothelial cell protein kinase Ca via oxidation. J. Immunol. 2006, 177, 6379-6387.
62. Tran, K., Proulx, P.-R., Chan, A.-C., Vitamin E suppresses diacylglycerol (DAG) level in thrombin stimulated endothelial cells through an increase in DAG kinase activity. Biochim. Biophys. Acta 1994, 1212, 193-202.
63. Kempna, P., Reiter, E., Arock, M., Azzi, A., Zingg, J.-M., Inhibition of HMC1 mast cell proliferation by vitamin E: involvement of the protein kinase B pathway. J. Biol. Chem. 2004,279,50700-50709.
64. Vejux, A., Guyot, S., Montange, T., Riedinger, J.-M. et al., Phospholipidosis and down-regulation of the PI3-K/PDK-1/ Akt signalling pathway are vitamin E inhibitable events associated with 7-ketocholesterol-induced apoptosis. J. Nutr. Biochem. 2009, 20, 45-61.
65. Chan, S.-S., Monteiro, H.-P., Schindler, F., Stern, A., Junqueira, V.-B., Alphα-tocopherol modulates tyrosine phosphorylation human neutrophils by inhibition of protein kinase C activity and activation of tyrosine phosphatases. Free Radic. Res. 2001, 35, 843-856.
66. Priemé, H., Loft, S., Nyyssönen, K., Salonen, J.-T., Poulsen, H.-E., No effect of supplementation with vitamin E, ascorbic acid, or coenzyme Q10 on oxidative DNA damage estimated by 8-oxo-7,8-dihydro-2'-deoxyguanosine excretion in smokers. Am. J. Clin. Nutr. 1997, 65, 503-507.
67. Atkinson, J., Epand, R.-F., Epand, R.-M., Tocopherols and tocotrienols in membranes: a critical review. Free Radic. Biol. Med. 2008, 44, 739-764.
68. Ohyashiki, T., Ushiro, H., Mohri, T., Effects of alphα-tocopherol on the lipid peroxidation and fluidity of porcine intestinal brush-border membranes. Biochim. Biophys. Acta 1986, 858, 294-300.
69. Quinn, P.-J., Molecular associations of vitamin E. Vitam. Horm. 2007, 76, 67-98.
70. Royer, M.-C., Lemaire-Ewing, S., Desrumaux, C., Monier, S. et al., 7-ketocholesterol incorporation into sphingolipid/ cholesterol-enriched (lipid raft) domains is impaired by Vitamin E: a specific role for alphα-tocopherol with consequences on cell death. J. Biol. Chem. 2009, 284, 15826-15834.
71. Boscoboinik, D., Szewczyk, A., Hensey, C., Azzi, A., Inhibition of cell proliferation by α-tocopherol. Role of protein kinase C. J. Biol. Chem. 1991, 266, 6188-6194.
72. Ricciarelli, R., Tasinato, A., Clement, S., Ozer, N.-K. et al., Alphα-tocopherol specifically inactivates cellular protein kinase C alpha by changing its phosphorylation state. Biochem. J. 1998, 334, 243-249.
73. Boudreau, R.-T., Garduno, R., Lin, T.-J., Protein Phosphatase 2A and Protein Kinase Ca are physically associated and are involved in Pseudomonas aeruginosa-induced interleukin 6 production by mast cells. J. Biol. Chem. 2002, 277, 5322-5329.
74. Berrou, E., Bryckaert, M., Recruitment of protein phosphatase 2A to dorsal ruffles by platelet-derived growth factor in smooth muscle cells: dephosphorylation of Hsp27. Exp. Cell Res. 2009, 315, 836-848.
75. Lasserre, R., Guo, X.-J., Conchonaud, F., Hamon, Y. et al., Raft nanodomains contribute to Akt/PKB plasma membrane recruitment and activation. Nat. Chem. Biol 2008, 4, 538-547.
76. Fukunaga-Takenaka, R., Shirai, Y., Yagi, K., Adachi, N. et al., Importance of chroman ring and tyrosine phosphorylation in the subtype specific translocation and activation of diacylglycerol kinase alpha by D-alphα-tocopherol. Genes Cells 2005, 10, 311-319.
77. Cuschieri, J., Bulger, E., Biligren, J., Garcia, I., Maier, R.-V., Vitamin E inhibits endotoxin-mediated transport of phosphatases to lipid rafts. Shock 2007, 27, 19-24.
78. Tasinato, A., Boscoboinick, D., Bartoli, G.-M., Maroni, P., Azzi, A., d-alphα-tocopherol inhibition of vascular smooth muscle cell proliferation occurs at physiological concentrations, correlates with protein kinase C inhibition, and is independent of its antioxidant properties. Proc. Natl. Acad. Sci. USA 1995, 92, 12190-12194.
79. 1 T cells is reversed by vitamin E supplementation. J. Immunol. 2007, 178, 1443-1449.
80. Van Komen, J.-S., Mishra, S., Byrum, J., Chichili, G.-R. et al., Early and dynamic polarization of T cell membrane rafts and constituents prior to TCR stop signals. J. Immunol. 2007,179,6845-6855.
81. Marko, M.-G., Pang, H.-J., Ren, Z., Azzi, A. et al., Vitamin E reverses impaired linker for activation of T cells activation in T cells from aged C57BL/6 mice. J. Nutr. 2009, 139, 1192-1197.
82. Miguet-Alfonsi, C., Prunet, C., Monier, S., Bessède, G. et al., Analysis of oxidative processes and of myelin Figs formation before and after the loss of mitochondrial transmem-brane potential during 7-beta-hydroxycholesterol and 7-ketocholesterol-induced apoptosis: comparison with various pro-apoptotic chemicals. Biochem. Pharmacol. 2002,64,527-541.
83. Lizard, G., Miguet, C., Bessède, G., Monier, S. et al., Impairment with various antioxydants of the loss of mitochondrial transmembrane potential and of the cytosolic release of cytochrome c occurring during 7-ketocholesterol-induced apoptosis. Free Radic. Biol. Med. 2000, 28, 743-753.
84. Burlacu, A., Regulation of apoptosis by Bcl-2 family proteins. J. Cell. Mol. Med. 2003, 7, 249-257.
85. Blume-Jensen, P., Janknecht, R., Hunter, T., The kit receptor promotes cell survival via activation of PI 3-kinase and subsequent Akt-mediated phosphorylation of Bad on Ser136. Curr. Biol. 1998, 8, 779-782.
86. Zha, J., Harada, H., Yang, E., Jockel, J., Korsmeyer, S.-J., Serine phosphorylation of death agonist BAD in response to survival factor results in binding to 14-3-3 not BCL-XL. Cell 1996, 87, 619-628.
87. Friedrichs, B., Toborek, M., Hennig, B., Heinevetter, L. et al., 13-HPODE and 13-HODE modulate cytokine-induced expression of endothelial cell adhesion molecules differently. Biofactors 1999, 9, 61-72.